Long-Term Treatment of Metastatic Colorectal Cancer with Panitumumab

Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. More than 30% patients present with metastases at diagnoses and will require systemic chemotherapy. In recent years many anti-EGFR targets have been developed. Among them, panitumumab, a fully human IgG2 monoclonal an...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gómez, Miriam, Merino, María, Casado, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296490/
https://www.ncbi.nlm.nih.gov/pubmed/22408376
http://dx.doi.org/10.4137/CMO.S5055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296490/
https://www.ncbi.nlm.nih.gov/pubmed/22408376
http://dx.doi.org/10.4137/CMO.S5055

Ejemplares similares